Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Orthopaedics and Related Research"
DOI: 10.1097/corr.0000000000002335
Abstract: Abstract Background The double-blind, randomized, placebo-controlled phase 3 study of orally administered PLX3397 in patients with pigmented villonodular synovitis or giant cell tumor of the tendon sheath (ENLIVEN) showed that pexidartinib provides a robust objective… read more here.
Keywords: response; worst pain; pexidartinib; pain ... See more keywords
Distinct Worst Pain Profiles in Oncology Outpatients Undergoing Chemotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "Cancer nursing"
DOI: 10.1097/ncc.0000000000001095
Abstract: BACKGROUND While pain is a significant problem for oncology patients, little is known about interindividual variability in pain characteristics. OBJECTIVE The aims of this study were to identify subgroups of patients with distinct worst pain… read more here.
Keywords: distinct worst; pain; worst pain; pain characteristics ... See more keywords
Worst pain intensity and opioid intake during the early postoperative period were not associated with moderate-severe pain 12 months after total knee arthroplasty – a longitudinal study
Sign Up to like & getrecommendations! Published in 2022 at "Scandinavian Journal of Pain"
DOI: 10.1515/sjpain-2022-0007
Abstract: Abstract Objectives There are several known predictors of pain after total knee arthroplasty (TKA). However, it is unclear whether acute postoperative pain intensity and postoperative opioid intake are associated with pain 12 months after TKA.… read more here.
Keywords: opioid intake; pain intensity; worst pain; pain months ... See more keywords